These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3474430)

  • 1. [Clinical laboratory approach for estimating effective administrative dose of ceftizoxime. Observation from MIC and ceftizoxime disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1987 Feb; 40(2):331-9. PubMed ID: 3474430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical laboratory approach for estimating the effective administrative dose of latamoxef. Significance of a 4-category system interpretation of the latamoxef disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1987 Nov; 40(11):1906-16. PubMed ID: 3327966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical laboratory approach for estimating effective administrative dosage of cefmenoxime. Observation on the MICS and cefmenoxime disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1984 May; 37(5):791-801. PubMed ID: 6090721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical laboratory approach to estimate effective administrative dose of minocyclin. Reevaluation of in vitro MIC break points in disc susceptibility test].
    Uete G; Matsuo K; Uete T
    Jpn J Antibiot; 1990 Sep; 43(9):1545-58. PubMed ID: 2262962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical laboratory approach for estimating effective administrative dose of cefuzonam. Evaluation of disc susceptibility test and its interpretation system].
    Uete T; Matsuo K
    Jpn J Antibiot; 1988 Oct; 41(10):1407-17. PubMed ID: 3204654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical laboratory approach for estimating effective administrative dose of sulbactam/cefoperazone].
    Uete T; Matsuo K
    Jpn J Antibiot; 1988 Nov; 41(11):1578-90. PubMed ID: 3210296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical laboratory approach to evaluate efficacy of amikacin. Reevaluation of in vitro MIC break points in disc susceptibility test].
    Uete G; Matsuo K; Uete T
    Jpn J Antibiot; 1992 May; 45(5):489-501. PubMed ID: 1512934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical laboratory approach for estimating effective administrative dose of cephalothin. Reevaluation of MIC break points in 4 category system of disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1989 Sep; 42(9):1900-12. PubMed ID: 2810753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical laboratory approach for estimating effective administrative dose of cefoperazone. Evaluation of disc susceptibility test and its interpretation system].
    Matsuo K; Uete T
    Jpn J Antibiot; 1988 Oct; 41(10):1418-29. PubMed ID: 3204655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical laboratory approach in estimating the effective dosage of cefamandole].
    Uete G; Matsuo K; Uete T
    Jpn J Antibiot; 1988 Jun; 41(6):631-40. PubMed ID: 3221428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical laboratory approach in estimating effective administrative dose of piperacillin. Reevaluation of MIC break points in 3 and 4 category systems of disc susceptibility test].
    Matsuo K; Uete T
    Jpn J Antibiot; 1990 Sep; 43(9):1559-71. PubMed ID: 2262963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical laboratory approach to estimating the effective administration dose of imipenem/cilastatin. Evaluation of the disk susceptibility test and its interpretation system].
    Matsuo K; Uete T
    Jpn J Antibiot; 1989 Nov; 42(11):2377-92. PubMed ID: 2621780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K; Uete T
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical laboratory approach for estimating effective administrative dose of cefsulodin].
    Uete T; Matsuo K
    Jpn J Antibiot; 1984 Sep; 37(9):1652-60. PubMed ID: 6439909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical laboratory approach for estimating effective administrative dose of tobramycin. Reevaluation of in vitro MIC break points of disk susceptibility test].
    Uete G; Matsuo K; Uete T
    Jpn J Antibiot; 1989 Sep; 42(9):1888-99. PubMed ID: 2810752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical laboratory approach to evaluate administration dose of arbekacin. Reevaluation of in vitro MIC break points in the disk susceptibility test].
    Matsuo K; Uete T
    Jpn J Antibiot; 1994 Aug; 47(8):1041-52. PubMed ID: 7933533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laboratory and clinical studies on ceftizoxime (author's transl)].
    Nishimura T; Tabuki K; Hiromatsu K; Takashima T; Kotani Y; Takagi M
    Jpn J Antibiot; 1982 Jan; 35(1):69-80. PubMed ID: 6279914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study on the disc sensitivity for ceftizoxime].
    Kanazawa Y; Kuramata T; Matsumoto K
    Jpn J Antibiot; 1986 Jan; 39(1):79-86. PubMed ID: 3457963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical laboratory approach for determination of effective dose of cefotiam. Observation from disc susceptibility test and MICs].
    Uete T; Tsuzaki Y; Furukawa S; Matsuo K
    Jpn J Antibiot; 1982 Jun; 35(6):1441-61. PubMed ID: 6290707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.